Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice
C. Garrett Rappazzo, Hannah C. Watkins, Cassandra Guarino, et al.
Vaccine (2016) Vol. 34, Iss. 10, pp. 1252-1258
Closed Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

Translating extracellular vesicle packaging into therapeutic applications
Dilara C. Ozkocak, Thanh Kha Phan, Ivan K. H. Poon
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Outer membrane vesicles: A bacterial-derived vaccination system
Linda A. Lieberman
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 37
Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
Rongjin Luo, Yanmin Chang, Huaizhen Liang, et al.
iMeta (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 18
Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application
Deming Li, Lisi Zhu, Yuxiao Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115120-115120
Open Access | Times Cited: 17
Bacterial Outer Membrane Vesicles (OMVs)-Based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV
Mahmoud Shehata, Ahmed Mostafa, Lisa Teubner, et al.
Vaccines (2019) Vol. 7, Iss. 2, pp. 46-46
Open Access | Times Cited: 45
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
Bacterial Extracellular Vesicles and the Gut‐Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics
Nicholas H. Pirolli, William E. Bentley, Steven M. Jay
Advanced Biology (2021) Vol. 5, Iss. 7
Closed Access | Times Cited: 36
Cytolysin A (ClyA): A Bacterial Virulence Factor with Potential Applications in Nanopore Technology, Vaccine Development, and Tumor Therapy
Kazunori Murase
Toxins (2022) Vol. 14, Iss. 2, pp. 78-78
Open Access | Times Cited: 23
Fight bacteria with bacteria: Bacterial membrane vesicles as vaccines and delivery nanocarriers against bacterial infections
Yingying Gan, Chengnan Li, Xinran Peng, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 35, pp. 102398-102398
Closed Access | Times Cited: 29
Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate
Leila Sadeghi, Azam Bolhassani, Elham Mohit, et al.
Microbial Pathogenesis (2024) Vol. 193, pp. 106749-106749
Closed Access | Times Cited: 4
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Cameron Bissett, Sandra Belij‐Rammerstorfer, Marta Ulaszewska, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Atypical artificial cells: Novel biomimetic materials for combating cancer
Zhao‐yang Ren, Qianqian Wan, Yi‐na Zhu, et al.
Interdisciplinary materials (2024) Vol. 3, Iss. 5, pp. 658-714
Open Access | Times Cited: 4
Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses
W. Wang, Ekramy E. Sayedahmed, Marwa Alhashimi, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 95-95
Open Access
Harnessing the therapeutic potential of bacterial extracellular vesicles via functional peptides
Yejiao Shi, Zhihong Zheng, Wen Wang, et al.
Deleted Journal (2025)
Open Access
Bacterial Extracellular Vesicles and Antimicrobial Peptides: A Synergistic Approach to Overcome Antimicrobial Resistance
Corina Ciobănaşu
Antibiotics (2025) Vol. 14, Iss. 4, pp. 414-414
Open Access
Protective efficacy of Fc targeting conserved influenza virus M2e antigen expressed by Lactobacillus plantarum
Wentao Yang, Guilian Yang, Qian Wang, et al.
Antiviral Research (2016) Vol. 138, pp. 9-21
Closed Access | Times Cited: 36
A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles
Hannah C. Watkins, Catalina L. Pagan, Hannah R. Childs, et al.
Vaccine (2017) Vol. 35, Iss. 40, pp. 5373-5380
Open Access | Times Cited: 34
A bacterial outer membrane vesicle-based click vaccine elicits potent immune response against Staphylococcus aureus in mice
Jingjing Sun, Xuansheng Lin, Yige He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
High performance anion exchange chromatography purification of probiotic bacterial extracellular vesicles enhances purity and anti‐inflammatory efficacy
Nicholas H. Pirolli, Laura Samantha C. Reus, Zuzanna Mamczarz, et al.
Biotechnology and Bioengineering (2023) Vol. 120, Iss. 11, pp. 3368-3380
Open Access | Times Cited: 10
Vaccine development: obligate intracellular bacteria new tools, old pathogens: the current state of vaccines against obligate intracellular bacteria
Erin J. van Schaik, Alycia P. Fratzke, Anthony E. Gregory, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Genetically surface-modified Escherichia coli outer membrane vesicles targeting MUC1 antigen in cancer cells
Sedthawut Laotee, Wanatchaporn Arunmanee
Biotechnology Reports (2024) Vol. 44, pp. e00854-e00854
Open Access | Times Cited: 3
Interspecies Communication between Pathogens and Immune Cells via Bacterial Membrane Vesicles
Katerina S. Jurkoshek, Ying Wang, Jaffre J. Athman, et al.
Frontiers in Cell and Developmental Biology (2016) Vol. 4
Open Access | Times Cited: 29
Lactobacillus plantarum displaying conserved M2e and HA2 fusion antigens induces protection against influenza virus challenge
Wentao Yang, Guilian Yang, Liang Zhao, et al.
Applied Microbiology and Biotechnology (2018) Vol. 102, Iss. 12, pp. 5077-5088
Closed Access | Times Cited: 29
Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
Qimin Wang, Yuling Zhang, Peng Zou, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 24
Transformable vesicles for cancer immunotherapy
Shuang Wang, Xiaoming Hu, Wei Wei, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113905-113905
Closed Access | Times Cited: 23

Scroll to top